Sign In
Buy APNHY
$8.79
-0.0750 (-0.85%)
At Close: Jun 03, 2026
Aspen Pharmacare Holdings Limited (APNHY) Shareholder/Analyst Call Prepared Remarks Transcript
11:14am, Friday, 29'th May 2026
Aspen Pharmacare Holdings Limited (APNHY) Shareholder/Analyst Call Prepared Remarks Transcript
Aspen Pharmacare Holdings Limited (APNHY) Q2 2026 Earnings Call Transcript
07:02am, Wednesday, 04'th Mar 2026
Aspen Pharmacare Holdings Limited (APNHY) Q2 2026 Earnings Call Transcript
Aspen Pharmacare aims for Canada entry with Ozempic generic by third quarter
08:54am, Tuesday, 03'rd Mar 2026
Aspen Pharmacare's unbranded version of Novo Nordisk's popular diabetes drug Ozempic could be registered in Canada in the second or third quarter of this year, the South African pharmac
Aspen Pharmacare Holdings Limited (APNHY) Discusses Proposed Divestment of APAC Operations Excluding China Transcript
01:15pm, Thursday, 15'th Jan 2026
Aspen Pharmacare Holdings Limited (APNHY) Discusses Proposed Divestment of APAC Operations Excluding China Transcript
Aspen Pharmacare Holdings Limited (APNHY) Q4 2025 Earnings Call Transcript
09:01am, Thursday, 04'th Sep 2025
Aspen Pharmacare Holdings Limited (OTCPK:APNHY) Q4 2025 Earnings Call September 4, 2025 2:30 AM EDT Company Participants Sanelisiwe Tonga Stephen Saad - Group CEO & Executive Director Sean Capazorio -
Aspen Pharmacare Holdings Limited (APNHF) Q2 2025 Earnings Call Transcript
02:20pm, Tuesday, 04'th Mar 2025
Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q2 2025 Results Conference Call March 4, 2025 1:30 AM ET Company Participants Sibongakonke Nkosi - Investor Relations Stephen Saad - Group Chief Executi
Aspen Pharmacare Holdings Limited (APNHF) Q4 2024 Earnings Call Transcript
12:47pm, Wednesday, 04'th Sep 2024
Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q4 2024 Earnings Conference Call September 4, 2024 2:30 AM ET Company Participants Sibongakonke Nkosi - Investor Relations Stephen Saad - Group Chief Ex
Aspen Pharmacare Holdings Limited (APNHF) Q4 2023 Earnings Call Transcript
03:09pm, Thursday, 31'st Aug 2023
Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q4 2023 Results Conference Call August 31, 2023 2:30 AM ET Company Participants Sibongakonke N. - Investor Relations Manager Stephen Saad - Chief Execut
Aspen Pharmacare Holdings Limited (APNHF) Q4 2022 Earnings Call Transcript
09:26am, Thursday, 01'st Sep 2022
Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q4 2022 Earnings Conference Call September 1, 2022 2:30 AM ET Company Participants Kuseni Dlamini - Chairman Sean Capazorio - Group Chief Financial Offi
New Strong Sell Stocks for July 11th
09:19am, Monday, 11'th Jul 2022
APNHY, AHCHY, and AMK have been added to the Zacks Rank #5 (Strong Sell) List on July 11, 2022.
New Strong Sell Stocks for March 22nd
10:32am, Tuesday, 22'nd Mar 2022
APNHY,BRY, and CSIQ have been added to the Zacks Rank #5 (Strong Sell) List on March 22, 2022.
Aspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad on Interim 2022 Results - Earnings Call Transcript
03:43am, Friday, 11'th Mar 2022 Seeking AlphaAspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad on Interim 2022 Results - Earnings Call Transcript
10:43pm, Thursday, 10'th Mar 2022
Aspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad on Interim 2022 Results - Earnings Call Transcript
Aspen Pharmacare Holdings Limited 2022 Q2 - Results - Earnings Call Presentation
05:02pm, Thursday, 10'th Mar 2022 Seeking Alpha
Aspen Pharmacare Holdings reports 1H results (OTCMKTS:APNHF)
09:41pm, Wednesday, 09'th Mar 2022 Seeking Alpha
Aspen Pharmacare Holdings press release (APNHF): 1H Normalized headline earnings per share ((NHEPS)) increased 21% to R$8.16
